article thumbnail

Open Source “Wikipedia” for Drug Discovery

Pharma Mirror

Despite untold investment by numerous pharmaceutical companies, FDA-approved drugs that target critical brain functions and conditions like anxiety, depression, and sedation continue to present severe and unpredictable side effects, including suicidal ideation. In 2003 the Human Genome Project provided the first atlas.

article thumbnail

Deep Dive: Patients and Partnerships

pharmaphorum

Medscape’s Adrian Duncan explores findings from an FDA trial looking at the impact of digital medical education on antibiotic prescribing. Emma Sutcliffe explains how to build partnerships that are not defined by the volume of the interactions but instead by the value that each interaction brings to all stakeholders.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Making a big impact in small patient populations

pharmaphorum

Pharmaceutical companies have long taken notice of this opportunity, developing a wave of therapies that are now entering the market. FDA data indicates that while the number of orphan designations has been increasing over the last half-decade, the number of unique indications has been decreasing 3.

article thumbnail

Twenty Women Leaders In Healthcare Industry

PharmaShots

Award & Nominations: For her contributions to the pharmaceutical sector and business, Emma received the rank of Dame Commander (DBE) in the 2020 Queen's Birthday Honours. With more than $50 billion in annual global revenue, Janssen has grown to be the second-largest innovative pharmaceutical company under her direction.

FDA 40
article thumbnail

Ep. 001 – John Mack Podcast Transcript

Pharma Marketing Network

Yeah, I even wanted to wear the shirt to this FDA meeting. You know, in November 2009, the FDA held a public hearing about the promotion of Food and Drug Administrative Related Regulated Medical Products, using the internet and social media tools. It wasn’t just pharmaceutical companies and others.

article thumbnail

CMC Requirements for New Drug Registration in Latin America

ISPE

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. Modernization of the FDA CDER Export Certificate Program.”

article thumbnail

Research Triangle: Building a Foundation for Pharmaceutical and Biotechnology Excellence

ISPE

Surrounded by universities and community colleges with life sciences programs, companies in RTP were able to access highly skilled graduates, increasing employment in the state. By the 1990s, pharmaceutical companies were looking to partner with contract research organizations (CROs) for drug development and clinical trials.